| 1 | [SID14736776] | Active | Potency | 2.3323 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | Potency | 2.3323 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID14736776] | Active | EC50 | 3.2 | Multiplexed dose response screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bfl-1. [AID1320, Type: confirmatory] | bcl-2-related protein A1 isoform 1 [Homo sapiens] [gi:4757840] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | EC50 | 3.2 [uM] | | BioAssay | Multiplexed dose response screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bfl-1. | | AID | 1320 | | BioAssay type | confirmatory | | Target | bcl-2-related protein A1 isoform 1 [Homo sapiens] [gi:4757840] | | PubMed | | | Data Table |  |
|
| 3 | [SID14736776] | Active | EC50 | 3.2 | Multiplexed dose response screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bfl-1. [AID1320, Type: confirmatory] | bcl-2-related protein A1 isoform 1 [Homo sapiens] [gi:4757840] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | EC50 | 3.2 [uM] | | BioAssay | Multiplexed dose response screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bfl-1. | | AID | 1320 | | BioAssay type | confirmatory | | Target | bcl-2-related protein A1 isoform 1 [Homo sapiens] [gi:4757840] | | PubMed | | | Data Table |  |
|
| 4 | [SID14736776] | Active | Potency | 3.9716 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia [AID2451, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | Potency | 3.9716 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia | | AID | 2451 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 5 | [SID14736776] | Active | EC50 | 4.1 | Confirmation Dose Response screen for compounds that protect hERG from block by proarrhythmic agents [AID2121, Type: confirmatory] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | EC50 | 4.1 [uM] | | BioAssay | Confirmation Dose Response screen for compounds that protect hERG from block by proarrhythmic agents | | AID | 2121 | | BioAssay type | confirmatory | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 6 | [SID14736776] | Active | EC50 | 4.1 | Confirmation Dose Response screen for compounds that protect hERG from block by proarrhythmic agents [AID2121, Type: confirmatory] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | EC50 | 4.1 [uM] | | BioAssay | Confirmation Dose Response screen for compounds that protect hERG from block by proarrhythmic agents | | AID | 2121 | | BioAssay type | confirmatory | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 7 | [SID14736776] | Active | EC50 | 4.1 | Confirmation Dose Response screen for compounds that protect hERG from block by proarrhythmic agents [AID2121, Type: confirmatory] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | EC50 | 4.1 [uM] | | BioAssay | Confirmation Dose Response screen for compounds that protect hERG from block by proarrhythmic agents | | AID | 2121 | | BioAssay type | confirmatory | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 8 | [SID14736776] | Active | EC50 | 4.1 | Confirmation Dose Response screen for compounds that protect hERG from block by proarrhythmic agents [AID2121, Type: confirmatory] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | EC50 | 4.1 [uM] | | BioAssay | Confirmation Dose Response screen for compounds that protect hERG from block by proarrhythmic agents | | AID | 2121 | | BioAssay type | confirmatory | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 9 | [SID14736776] | Active | EC50 | 4.1 | Confirmation Dose Response screen for compounds that protect hERG from block by proarrhythmic agents [AID2121, Type: confirmatory] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | EC50 | 4.1 [uM] | | BioAssay | Confirmation Dose Response screen for compounds that protect hERG from block by proarrhythmic agents | | AID | 2121 | | BioAssay type | confirmatory | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 10 | [SID14736776] | Active | EC50 | 4.644 | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Inhibitors of Streptokinase Promotor Activity [AID1902, Type: confirmatory] | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | EC50 | 4.644 [uM] | | BioAssay | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Inhibitors of Streptokinase Promotor Activity | | AID | 1902 | | BioAssay type | confirmatory | | Target | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] | | PubMed | | | Data Table |  |
|
| 11 | [SID14736776] | Active | EC50 | 6.536 | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to SK(-)GAS Group A Streptococcus [AID1900, Type: confirmatory] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | EC50 | 6.536 [uM] | | BioAssay | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to SK(-)GAS Group A Streptococcus | | AID | 1900 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID14736776] | Active | EC50 | 6.905 | Luminescence Microorganism-Based Dose Response HTS to Identify Compounds Cytotoxic to Streptococcus [AID1915, Type: confirmatory] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | EC50 | 6.905 [uM] | | BioAssay | Luminescence Microorganism-Based Dose Response HTS to Identify Compounds Cytotoxic to Streptococcus | | AID | 1915 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID14736776] | Active | IC50 | 7.037 | Dose response cell-based assay to measure STAT3 inhibition [AID1399, Type: confirmatory] | STAT3 [Homo sapiens] [gi:13272532] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | IC50 | 7.037 [uM] | | BioAssay | Dose response cell-based assay to measure STAT3 inhibition | | AID | 1399 | | BioAssay type | confirmatory | | Target | STAT3 [Homo sapiens] [gi:13272532] | | PubMed | | | Data Table |  |
|
| 14 | [SID14736776] | Active | IC50 | 7.037 | Dose response cell-based assay to measure STAT3 inhibition [AID1399, Type: confirmatory] | STAT3 [Homo sapiens] [gi:13272532] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | IC50 | 7.037 [uM] | | BioAssay | Dose response cell-based assay to measure STAT3 inhibition | | AID | 1399 | | BioAssay type | confirmatory | | Target | STAT3 [Homo sapiens] [gi:13272532] | | PubMed | | | Data Table |  |
|
| 15 | [SID14736776] | Active | IC50 | 7.037 | Dose response cell-based assay to measure STAT3 inhibition [AID1399, Type: confirmatory] | STAT3 [Homo sapiens] [gi:13272532] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | IC50 | 7.037 [uM] | | BioAssay | Dose response cell-based assay to measure STAT3 inhibition | | AID | 1399 | | BioAssay type | confirmatory | | Target | STAT3 [Homo sapiens] [gi:13272532] | | PubMed | | | Data Table |  |
|
| 16 | [SID14736776] | Active | Potency | 7.9433 | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) [AID1490, Type: confirmatory] | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) | | AID | 1490 | | BioAssay type | confirmatory | | Target | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] | | PubMed | | | Data Table |  |
|
| 17 | [SID14736776] | Active | Potency | 8.9125 | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins [AID485364, Type: confirmatory] | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins | | AID | 485364 | | BioAssay type | confirmatory | | Target | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] | | PubMed | | | Data Table |  |
|
| 18 | [SID14736776] | Active | Potency | 8.9125 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 19 | [SID14736776] | Active | Potency | 10 | qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2) [AID881, Type: confirmatory] | Arachidonate 15-lipoxygenase B [gi:317373425] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2) | | AID | 881 | | BioAssay type | confirmatory | | Target | Arachidonate 15-lipoxygenase B [gi:317373425] | | PubMed | | | Data Table |  |
|
| 20 | [SID14736776] | Active | Potency | 10 | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction [AID1461, Type: confirmatory] | NPSR1 gene product [Homo sapiens] [gi:46395496] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction | | AID | 1461 | | BioAssay type | confirmatory | | Target | NPSR1 gene product [Homo sapiens] [gi:46395496] | | PubMed | | | Data Table |  |
|
| 21 | [SID14736776] | Active | Potency | 10 | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction [AID1461, Type: confirmatory] | NPSR1 gene product [Homo sapiens] [gi:46395496] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction | | AID | 1461 | | BioAssay type | confirmatory | | Target | NPSR1 gene product [Homo sapiens] [gi:46395496] | | PubMed | | | Data Table |  |
|
| 22 | [SID14736776] | Active | Potency | 11.2202 | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 23 | [SID14736776] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory] | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) | | AID | 894 | | BioAssay type | confirmatory | | Target | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] | | PubMed | | | Data Table |  |
|
| 24 | [SID14736776] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory] | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) | | AID | 894 | | BioAssay type | confirmatory | | Target | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] | | PubMed | | | Data Table |  |
|
| 25 | [SID14736776] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory] | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) | | AID | 894 | | BioAssay type | confirmatory | | Target | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] | | PubMed | | | Data Table |  |
|
| 26 | [SID14736776] | Active | Potency | 13.4591 | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) [AID588342, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | Potency | 13.4591 [uM] | | BioAssay | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) | | AID | 588342 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|
| 27 | [SID14736776] | Active | Potency | 15.8489 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 28 | [SID14736776] | Active | Potency | 15.8489 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 29 | [SID14736776] | Active | Potency | 22.3872 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 30 | [SID14736776] | Active | Potency | 35.4813 | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization [AID1468, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization | | AID | 1468 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 31 | [SID14736776] | Active | Potency | 35.4813 | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization [AID1468, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization | | AID | 1468 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 32 | [SID14736776] | Active | | | HTS identification of compounds inhibiting the binding of CD11b/CD18 to fibrinogen via a luminescence assay. [AID1497, Type: screening] | integrin alpha-M isoform 2 precursor [Homo sapiens] [gi:88501734] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | BioAssay | HTS identification of compounds inhibiting the binding of CD11b/CD18 to fibrinogen via a luminescence assay. | | AID | 1497 | | BioAssay type | screening | | Target | integrin alpha-M isoform 2 precursor [Homo sapiens] [gi:88501734] | | PubMed | | | Data Table |  |
|
| 33 | [SID14736776] | Active | | | HTS identification of compounds inhibiting the binding of CD11b/CD18 to fibrinogen via a luminescence assay. [AID1497, Type: screening] | integrin alpha-M isoform 2 precursor [Homo sapiens] [gi:88501734] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | BioAssay | HTS identification of compounds inhibiting the binding of CD11b/CD18 to fibrinogen via a luminescence assay. | | AID | 1497 | | BioAssay type | screening | | Target | integrin alpha-M isoform 2 precursor [Homo sapiens] [gi:88501734] | | PubMed | | | Data Table |  |
|
| 34 | [SID14736776] | Active | | | High throughput discovery of novel modulators of ROMK K+ channel activity: Retest of Primary Hits [AID1917, Type: other] | Potassium inwardly-rectifying channel, subfamily J, member 1 [Homo sapiens] [gi:223460826] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | BioAssay | High throughput discovery of novel modulators of ROMK K+ channel activity: Retest of Primary Hits | | AID | 1917 | | BioAssay type | other | | Target | Potassium inwardly-rectifying channel, subfamily J, member 1 [Homo sapiens] [gi:223460826] | | PubMed | | | Data Table |  |
|
| 35 | [SID14736776] | Active | | | High throughput discovery of novel modulators of ROMK K+ channel activity: Primary Screen [AID1918, Type: screening] | Potassium inwardly-rectifying channel, subfamily J, member 1 [Homo sapiens] [gi:223460826] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | BioAssay | High throughput discovery of novel modulators of ROMK K+ channel activity: Primary Screen | | AID | 1918 | | BioAssay type | screening | | Target | Potassium inwardly-rectifying channel, subfamily J, member 1 [Homo sapiens] [gi:223460826] | | PubMed | | | Data Table |  |
|
| 36 | [SID14736776] | Active | | | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents [AID1835, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | BioAssay | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents | | AID | 1835 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 37 | [SID14736776] | Active | | | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents [AID1835, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | BioAssay | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents | | AID | 1835 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 38 | [SID14736776] | Active | | | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents [AID1835, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | BioAssay | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents | | AID | 1835 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 39 | [SID14736776] | Active | | | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents [AID1835, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | BioAssay | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents | | AID | 1835 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 40 | [SID14736776] | Active | | | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents [AID1835, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | BioAssay | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents | | AID | 1835 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 41 | [SID14736776] | Active | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 42 | [SID14736776] | Active | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 43 | [SID14736776] | Active | | | Confirmation cell-based high throughput screening assay to measure STAT3 inhibition [AID1265, Type: screening] | STAT3 [Homo sapiens] [gi:13272532] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | BioAssay | Confirmation cell-based high throughput screening assay to measure STAT3 inhibition | | AID | 1265 | | BioAssay type | screening | | Target | STAT3 [Homo sapiens] [gi:13272532] | | PubMed | | | Data Table |  |
|
| 44 | [SID14736776] | Active | | | Confirmation cell-based high throughput screening assay to measure STAT3 inhibition [AID1265, Type: screening] | STAT3 [Homo sapiens] [gi:13272532] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | BioAssay | Confirmation cell-based high throughput screening assay to measure STAT3 inhibition | | AID | 1265 | | BioAssay type | screening | | Target | STAT3 [Homo sapiens] [gi:13272532] | | PubMed | | | Data Table |  |
|
| 45 | [SID14736776] | Active | | | Confirmation cell-based high throughput screening assay to measure STAT3 inhibition [AID1265, Type: screening] | STAT3 [Homo sapiens] [gi:13272532] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | BioAssay | Confirmation cell-based high throughput screening assay to measure STAT3 inhibition | | AID | 1265 | | BioAssay type | screening | | Target | STAT3 [Homo sapiens] [gi:13272532] | | PubMed | | | Data Table |  |
|
| 46 | [SID14736776] | Active | | | Primary cell-based high throughput screening assay to measure STAT3 inhibition [AID862, Type: screening] | STAT3 [Homo sapiens] [gi:13272532] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | BioAssay | Primary cell-based high throughput screening assay to measure STAT3 inhibition | | AID | 862 | | BioAssay type | screening | | Target | STAT3 [Homo sapiens] [gi:13272532] | | PubMed | | | Data Table |  |
|
| 47 | [SID14736776] | Active | | | Primary cell-based high throughput screening assay to measure STAT3 inhibition [AID862, Type: screening] | STAT3 [Homo sapiens] [gi:13272532] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | BioAssay | Primary cell-based high throughput screening assay to measure STAT3 inhibition | | AID | 862 | | BioAssay type | screening | | Target | STAT3 [Homo sapiens] [gi:13272532] | | PubMed | | | Data Table |  |
|
| 48 | [SID14736776] | Active | | | Primary cell-based high throughput screening assay to measure STAT3 inhibition [AID862, Type: screening] | STAT3 [Homo sapiens] [gi:13272532] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | BioAssay | Primary cell-based high throughput screening assay to measure STAT3 inhibition | | AID | 862 | | BioAssay type | screening | | Target | STAT3 [Homo sapiens] [gi:13272532] | | PubMed | | | Data Table |  |
|
| 49 | [SID14736776] | Active | | | uHTS of Mcl-1/Noxa interaction inhibitors [AID1022, Type: screening] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | BioAssay | uHTS of Mcl-1/Noxa interaction inhibitors | | AID | 1022 | | BioAssay type | screening | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 50 | [SID14736776] | Active | | | uHTS of Mcl-1/Noxa interaction inhibitors [AID1022, Type: screening] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 14736776 | | CID | 2841620 | | Outcome | Active | | BioAssay | uHTS of Mcl-1/Noxa interaction inhibitors | | AID | 1022 | | BioAssay type | screening | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|